⌘K

Login Start Free

Home/Filings/4/0001855763-21-000019

4//SEC Filing

DOCHERTY JOHN MARTIN 4

Accession 0001855763-21-000019

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Jun 8, 8:00 PM ET

Accepted

Jun 9, 1:34 PM ET

Size

9.6 KB

Accession

0001855763-21-000019

Insider Transaction Report

Form 4

Period: 2021-05-07

Lexaria Bioscience Corp.LEXX

DOCHERTY JOHN MARTIN

DirectorPresident

Transactions

Other
Stock Options
2021-05-07−18,334→ 31,334 total
Exercise: $14.10From: 2020-02-07Exp: 2025-02-07→ Common Shares (18,334 underlying)

Holdings

common shares
(indirect: Private Holding Company)
54,075
Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (13,334 underlying)
31,668
Stock Options
Exercise: $14.10From: 2020-02-07Exp: 2025-02-07→ Common Shares (18,334 underlying)
18,334
Stock Options
Exercise: $5.31From: 2021-04-26Exp: 2026-04-26→ Common Shares (18,000 underlying)
49,668

Footnotes (1)

[F1]Cancellation of Options

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001638727

Filing Metadata

Form type: 4
Filed: Jun 8, 8:00 PM ET
Accepted: Jun 9, 1:34 PM ET
Size: 9.6 KB

View on SEC.gov